Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03668119 |
|---|---|
| Brief Title: | A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H) (CheckMate 848) |
| First Submitted : | September 11, 2018 |
| First Submitted that Met QC Criteria : | September 11, 2018 |
| First Posted : | September 12, 2018 |
| Last Update Submitted that Met QC Criteria : | March 15, 2023 |
| Last Update Posted : | March 16, 2023 |